Prevention of atrial fibrillation. Report from a national heart, lung, and blood institute workshop

Emelia J. Benjamin, Peng Sheng Chen, Diane E. Bild, Alice M. Mascette, Christine M. Albert, Alvaro Alonso, Hugh Calkins, Stuart J. Connolly, Anne B. Curtis, Dawood Darbar, Patrick T. Ellinor, Alan S. Go, Nora F. Goldschlager, Susan R. Heckbert, José Jalife, Charles R. Kerr, Daniel Levy, Donald M. Lloyd-Jones, Barry M. Massie, Stanley Nattel & 7 others Jeffrey E. Olgin, Douglas L. Packer, Sunny S. Po, Teresa S M Tsang, David R. Van Wagoner, Albert L. Waldo, D. George Wyse

Research output: Contribution to journalArticle

Abstract

The National Heart, Lung, and Blood Institute convened an expert panel April 28 to 29, 2008, to identify gaps and recommend research strategies to prevent atrial fibrillation (AF). The panel reviewed the existing basic scientific, epidemiological, and clinical literature about AF and identified opportunities to advance AF prevention research. After discussion, the panel proposed the following recommendations: (1) enhance understanding of the epidemiology of AF in the population by systematically and longitudinally investigating symptomatic and asymptomatic AF in cohort studies; (2) improve detection of AF by evaluating the ability of existing and emerging methods and technologies to detect AF; (3) improve noninvasive modalities for identifying key components of cardiovascular remodeling that promote AF, including genetic, fibrotic, autonomic, structural, and electrical remodeling markers; (4) develop additional animal models reflective of the pathophysiology of human AF; (5) conduct secondary analyses of already-completed clinical trials to enhance knowledge of potentially effective methods to prevent AF and routinely include AF as an outcome in ongoing and future cardiovascular studies; and (6) conduct clinical studies focused on secondary prevention of AF recurrence, which would inform future primary prevention investigations.

Original languageEnglish (US)
Pages (from-to)606-618
Number of pages13
JournalCirculation
Volume119
Issue number4
DOIs
StatePublished - Feb 3 2009

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Atrial Fibrillation
Education
Atrial Remodeling
Primary Prevention
Secondary Prevention
Research
Epidemiology

Keywords

  • Atrial fibrillation
  • Atrium
  • Epidemiology
  • National Heart, Lung, and Blood Institute
  • Prevention
  • Risk factors

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Benjamin, E. J., Chen, P. S., Bild, D. E., Mascette, A. M., Albert, C. M., Alonso, A., ... Wyse, D. G. (2009). Prevention of atrial fibrillation. Report from a national heart, lung, and blood institute workshop. Circulation, 119(4), 606-618. https://doi.org/10.1161/CIRCULATIONAHA.108.825380

Prevention of atrial fibrillation. Report from a national heart, lung, and blood institute workshop. / Benjamin, Emelia J.; Chen, Peng Sheng; Bild, Diane E.; Mascette, Alice M.; Albert, Christine M.; Alonso, Alvaro; Calkins, Hugh; Connolly, Stuart J.; Curtis, Anne B.; Darbar, Dawood; Ellinor, Patrick T.; Go, Alan S.; Goldschlager, Nora F.; Heckbert, Susan R.; Jalife, José; Kerr, Charles R.; Levy, Daniel; Lloyd-Jones, Donald M.; Massie, Barry M.; Nattel, Stanley; Olgin, Jeffrey E.; Packer, Douglas L.; Po, Sunny S.; Tsang, Teresa S M; Van Wagoner, David R.; Waldo, Albert L.; Wyse, D. George.

In: Circulation, Vol. 119, No. 4, 03.02.2009, p. 606-618.

Research output: Contribution to journalArticle

Benjamin, EJ, Chen, PS, Bild, DE, Mascette, AM, Albert, CM, Alonso, A, Calkins, H, Connolly, SJ, Curtis, AB, Darbar, D, Ellinor, PT, Go, AS, Goldschlager, NF, Heckbert, SR, Jalife, J, Kerr, CR, Levy, D, Lloyd-Jones, DM, Massie, BM, Nattel, S, Olgin, JE, Packer, DL, Po, SS, Tsang, TSM, Van Wagoner, DR, Waldo, AL & Wyse, DG 2009, 'Prevention of atrial fibrillation. Report from a national heart, lung, and blood institute workshop', Circulation, vol. 119, no. 4, pp. 606-618. https://doi.org/10.1161/CIRCULATIONAHA.108.825380
Benjamin, Emelia J. ; Chen, Peng Sheng ; Bild, Diane E. ; Mascette, Alice M. ; Albert, Christine M. ; Alonso, Alvaro ; Calkins, Hugh ; Connolly, Stuart J. ; Curtis, Anne B. ; Darbar, Dawood ; Ellinor, Patrick T. ; Go, Alan S. ; Goldschlager, Nora F. ; Heckbert, Susan R. ; Jalife, José ; Kerr, Charles R. ; Levy, Daniel ; Lloyd-Jones, Donald M. ; Massie, Barry M. ; Nattel, Stanley ; Olgin, Jeffrey E. ; Packer, Douglas L. ; Po, Sunny S. ; Tsang, Teresa S M ; Van Wagoner, David R. ; Waldo, Albert L. ; Wyse, D. George. / Prevention of atrial fibrillation. Report from a national heart, lung, and blood institute workshop. In: Circulation. 2009 ; Vol. 119, No. 4. pp. 606-618.
@article{c9c71d526227422d83028e6b2e34e4ad,
title = "Prevention of atrial fibrillation. Report from a national heart, lung, and blood institute workshop",
abstract = "The National Heart, Lung, and Blood Institute convened an expert panel April 28 to 29, 2008, to identify gaps and recommend research strategies to prevent atrial fibrillation (AF). The panel reviewed the existing basic scientific, epidemiological, and clinical literature about AF and identified opportunities to advance AF prevention research. After discussion, the panel proposed the following recommendations: (1) enhance understanding of the epidemiology of AF in the population by systematically and longitudinally investigating symptomatic and asymptomatic AF in cohort studies; (2) improve detection of AF by evaluating the ability of existing and emerging methods and technologies to detect AF; (3) improve noninvasive modalities for identifying key components of cardiovascular remodeling that promote AF, including genetic, fibrotic, autonomic, structural, and electrical remodeling markers; (4) develop additional animal models reflective of the pathophysiology of human AF; (5) conduct secondary analyses of already-completed clinical trials to enhance knowledge of potentially effective methods to prevent AF and routinely include AF as an outcome in ongoing and future cardiovascular studies; and (6) conduct clinical studies focused on secondary prevention of AF recurrence, which would inform future primary prevention investigations.",
keywords = "Atrial fibrillation, Atrium, Epidemiology, National Heart, Lung, and Blood Institute, Prevention, Risk factors",
author = "Benjamin, {Emelia J.} and Chen, {Peng Sheng} and Bild, {Diane E.} and Mascette, {Alice M.} and Albert, {Christine M.} and Alvaro Alonso and Hugh Calkins and Connolly, {Stuart J.} and Curtis, {Anne B.} and Dawood Darbar and Ellinor, {Patrick T.} and Go, {Alan S.} and Goldschlager, {Nora F.} and Heckbert, {Susan R.} and Jos{\'e} Jalife and Kerr, {Charles R.} and Daniel Levy and Lloyd-Jones, {Donald M.} and Massie, {Barry M.} and Stanley Nattel and Olgin, {Jeffrey E.} and Packer, {Douglas L.} and Po, {Sunny S.} and Tsang, {Teresa S M} and {Van Wagoner}, {David R.} and Waldo, {Albert L.} and Wyse, {D. George}",
year = "2009",
month = "2",
day = "3",
doi = "10.1161/CIRCULATIONAHA.108.825380",
language = "English (US)",
volume = "119",
pages = "606--618",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Prevention of atrial fibrillation. Report from a national heart, lung, and blood institute workshop

AU - Benjamin, Emelia J.

AU - Chen, Peng Sheng

AU - Bild, Diane E.

AU - Mascette, Alice M.

AU - Albert, Christine M.

AU - Alonso, Alvaro

AU - Calkins, Hugh

AU - Connolly, Stuart J.

AU - Curtis, Anne B.

AU - Darbar, Dawood

AU - Ellinor, Patrick T.

AU - Go, Alan S.

AU - Goldschlager, Nora F.

AU - Heckbert, Susan R.

AU - Jalife, José

AU - Kerr, Charles R.

AU - Levy, Daniel

AU - Lloyd-Jones, Donald M.

AU - Massie, Barry M.

AU - Nattel, Stanley

AU - Olgin, Jeffrey E.

AU - Packer, Douglas L.

AU - Po, Sunny S.

AU - Tsang, Teresa S M

AU - Van Wagoner, David R.

AU - Waldo, Albert L.

AU - Wyse, D. George

PY - 2009/2/3

Y1 - 2009/2/3

N2 - The National Heart, Lung, and Blood Institute convened an expert panel April 28 to 29, 2008, to identify gaps and recommend research strategies to prevent atrial fibrillation (AF). The panel reviewed the existing basic scientific, epidemiological, and clinical literature about AF and identified opportunities to advance AF prevention research. After discussion, the panel proposed the following recommendations: (1) enhance understanding of the epidemiology of AF in the population by systematically and longitudinally investigating symptomatic and asymptomatic AF in cohort studies; (2) improve detection of AF by evaluating the ability of existing and emerging methods and technologies to detect AF; (3) improve noninvasive modalities for identifying key components of cardiovascular remodeling that promote AF, including genetic, fibrotic, autonomic, structural, and electrical remodeling markers; (4) develop additional animal models reflective of the pathophysiology of human AF; (5) conduct secondary analyses of already-completed clinical trials to enhance knowledge of potentially effective methods to prevent AF and routinely include AF as an outcome in ongoing and future cardiovascular studies; and (6) conduct clinical studies focused on secondary prevention of AF recurrence, which would inform future primary prevention investigations.

AB - The National Heart, Lung, and Blood Institute convened an expert panel April 28 to 29, 2008, to identify gaps and recommend research strategies to prevent atrial fibrillation (AF). The panel reviewed the existing basic scientific, epidemiological, and clinical literature about AF and identified opportunities to advance AF prevention research. After discussion, the panel proposed the following recommendations: (1) enhance understanding of the epidemiology of AF in the population by systematically and longitudinally investigating symptomatic and asymptomatic AF in cohort studies; (2) improve detection of AF by evaluating the ability of existing and emerging methods and technologies to detect AF; (3) improve noninvasive modalities for identifying key components of cardiovascular remodeling that promote AF, including genetic, fibrotic, autonomic, structural, and electrical remodeling markers; (4) develop additional animal models reflective of the pathophysiology of human AF; (5) conduct secondary analyses of already-completed clinical trials to enhance knowledge of potentially effective methods to prevent AF and routinely include AF as an outcome in ongoing and future cardiovascular studies; and (6) conduct clinical studies focused on secondary prevention of AF recurrence, which would inform future primary prevention investigations.

KW - Atrial fibrillation

KW - Atrium

KW - Epidemiology

KW - National Heart, Lung, and Blood Institute

KW - Prevention

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=60749123546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60749123546&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.108.825380

DO - 10.1161/CIRCULATIONAHA.108.825380

M3 - Article

VL - 119

SP - 606

EP - 618

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 4

ER -